Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Fabrizio Amoruso

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Healthcare (Basel, Switzerland)|June 2, 2021
Ixekizumab May Improve Renal Function in PsoriasisGiuseppe Fabrizio Amoruso, Steven Paul Nisticò, Luigi Iannone, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
An Innovative Dual-Wavelength Laser Technique for Atrophic Acne Scar Management: A Pilot StudyStefania Belletti, Francesca Madeddu, Giuseppe Fabrizio Amoruso, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|January 15, 2021
A New 675 nm Laser Device in the Treatment of Facial Aging: A Prospective Observational StudyGiovanni Cannarozzo, Gilda Fazia, Luigi Bennardo, et al.
Acta Dermatovenerologica Croatica : ADC|August 2, 2018
Neurodystrophic Hand Dermatitis: Sannino Barduagni SyndromeUgo Bottoni, Stefania Tamburrini, Elisabetta Scali, et al.
Journal of the American Academy of Dermatology|July 24, 2024
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series studyElena Pezzolo, Alessandra Narcisi, Luigi Gargiulo, et al.
American Journal of Clinical Dermatology|March 16, 2021
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational StudyCataldo Patruno, Gabriella Fabbrocini, Giuseppe Longo, et al.
Journal of Clinical Medicine|January 23, 2024
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter AnalysisElena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, et al.
Clinics in Dermatology|November 17, 2021
The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in ItalyGiulio Gualdi, Annamaria Porreca, Giuseppe Fabrizio Amoruso, et al.
Paediatric Drugs|August 26, 2022
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life StudyMaddalena Napolitano, Gabriella Fabbrocini, Iria Neri, et al.
International Journal of Dermatology|May 24, 2022
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approachClara De Simone, Paolo Dapavo, Piergiorgio Malagoli, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Healthcare (Basel, Switzerland)|June 2, 2021
Ixekizumab May Improve Renal Function in PsoriasisGiuseppe Fabrizio Amoruso, Steven Paul Nisticò, Luigi Iannone, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
An Innovative Dual-Wavelength Laser Technique for Atrophic Acne Scar Management: A Pilot StudyStefania Belletti, Francesca Madeddu, Giuseppe Fabrizio Amoruso, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|January 15, 2021
A New 675 nm Laser Device in the Treatment of Facial Aging: A Prospective Observational StudyGiovanni Cannarozzo, Gilda Fazia, Luigi Bennardo, et al.
Acta Dermatovenerologica Croatica : ADC|August 2, 2018
Neurodystrophic Hand Dermatitis: Sannino Barduagni SyndromeUgo Bottoni, Stefania Tamburrini, Elisabetta Scali, et al.
Journal of the American Academy of Dermatology|July 24, 2024
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series studyElena Pezzolo, Alessandra Narcisi, Luigi Gargiulo, et al.
American Journal of Clinical Dermatology|March 16, 2021
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational StudyCataldo Patruno, Gabriella Fabbrocini, Giuseppe Longo, et al.
Journal of Clinical Medicine|January 23, 2024
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter AnalysisElena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, et al.
Clinics in Dermatology|November 17, 2021
The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in ItalyGiulio Gualdi, Annamaria Porreca, Giuseppe Fabrizio Amoruso, et al.
Paediatric Drugs|August 26, 2022
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life StudyMaddalena Napolitano, Gabriella Fabbrocini, Iria Neri, et al.
International Journal of Dermatology|May 24, 2022
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approachClara De Simone, Paolo Dapavo, Piergiorgio Malagoli, et al.
Pageof 1